Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • A Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity

    Not recruiting

    3 1
    Investigated drugs:
    Austria Germany Hungary Ireland Poland
  • Study comparing semaglutide and dapagliflozin taken separately or combined in one tablet for type 2 diabetes patients

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Germany
  • Study of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor

    Not recruiting

    2 1 1
    Bulgaria Croatia Germany Greece Hungary Poland +3
  • Study of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy

    Not recruiting

    2 1
    Investigated drugs:
    Denmark France Norway Spain
  • Study comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Hungary Poland Spain
  • Study of Orforglipron for Weight Management in People with Obesity or Overweight, With or Without Type 2 Diabetes

    Not recruiting

    3 1
    Czechia Germany
  • Study on Insulin Aspart for Recovery from Low Blood Sugar in People with and without Type 2 Diabetes

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria
  • Study on Personalized Treatment Using Dapagliflozin, Dulaglutide, and Metformin for Patients with Uncontrolled Type 2 Diabetes

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Spain
  • Study on the Effectiveness of Survodutide for Weight Loss in Patients with Type 2 Diabetes and Obesity

    Not recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Denmark Finland Germany Greece +5
  • Study of NNC0519-0130 and semaglutide in people with chronic kidney disease who are overweight or obese, with or without type 2 diabetes

    Not recruiting

    2 1 1
    Investigated drugs:
    Bulgaria Italy Poland Spain